Effects of lipolytic and inotropic stimulation on myocardial ischemic injury.
D000818:Animals; D002302:Cardiac Output / Q000187:drug effects; D002395:Catecholamines / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D003327:Coronary Disease / Q000188:drug therapy* / Q000378:metabolism; D004285:Dogs; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D006801:Humans; D007545:Isoproterenol / Q000494:pharmacology / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000188:drug therapy / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism; D009540:Nicotinyl Alcohol / Q000494:pharmacology / Q000627:therapeutic use*; D010101:Oxygen Consumption / Q000187:drug effects; D011725:Pyridines / Q000627:therapeutic use*
D002395:Catecholamines; D005230:Fatty Acids, Nonesterified; D011725:Pyridines; D009540:Nicotinyl Alcohol; D007545:Isoproterenol